Marshall Wace’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.7K | Buy |
+154,568
| New | +$92.7K | ﹤0.01% | 2405 |
|
|
2024
Q4 | – | Sell |
-50,570
| Closed | -$164K | – | 2737 |
|
|
2024
Q3 | $164K | Sell |
50,570
-106,049
| -68% | -$344K | ﹤0.01% | 2150 |
|
|
2024
Q2 | $470K | Sell |
156,619
-51,251
| -25% | -$154K | ﹤0.01% | 1806 |
|
|
2024
Q1 | $967K | Buy |
207,870
+54,345
| +35% | +$253K | ﹤0.01% | 1453 |
|
|
2023
Q4 | $636K | Buy |
+153,525
| New | +$636K | ﹤0.01% | 1355 |
|
|
2022
Q4 | – | Sell |
-96,254
| Closed | -$3.57M | – | 2757 |
|
|
2022
Q3 | $3.57M | Buy |
+96,254
| New | +$3.57M | 0.01% | 1322 |
|